| Generations Healthcare Services, Llc | |
| 4889 Sinclair Road, Suite 108b, Columbus, Ohio 43229 | |
| (614) 440-6231 | |
| Not Available |
| Name | Generations Healthcare Services, Llc |
|---|---|
| Location | 4889 Sinclair Road, Suite 108b, Columbus, Ohio |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Home Health Aide |
| Medicare ID | 368193 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 43110, 43113, 43205, 43211, 43214, 43215, 43224, 43227, 43228, 43230, 43232 |
| NPI Number | 1144335274 |
| Organization Name | GENERATIONS HEALTHCARE SERVICES LLC |
| Address | 4889 Sinclair Road, Suite 108b, Columbus, OH 43229 |
| Phone Number | 614-440-6231 |
News Archive
InformationConnections.org, the informative website for parents of children with developmental disabilities and chronic diseases, was recently launched by the Marianjoy Medical Library. The National Network of Libraries of Medicine, Greater Midwest Region, provided a grant to create and manage the website.
Repros Therapeutics Inc. today announced it has received IRB approval to commence the low dose Proellex® study. The contract for clinical services was previously awarded to ICON. The new low dose study is designed to explore both safety and signals of efficacy in an escalating dose fashion. The study will test 5 different doses of Proellex (1, 3, 6, 9 and 12 mg) with 1 mg being the first dose tested. In previous studies a 12.5 mg dose was well tolerated and yielded statistically significant efficacy signals for both uterine fibroids and endometriosis.
Some carbonated sodas and energy drinks are loaded with caffeine and can give an unhealthy pick-me-up to unsuspecting consumers, University of Florida researchers warn.
Researchers at Flinders University are expanding work on a promising blood test model to help predict or diagnose head and neck cancer, a difficult cancer to pick up early and treat.
AB SCIEX, a global leader in life science analytical technologies, today announced that it is collaborating with the Samuel Lunenfeld Research Institute of Mount Sinai Hospital, one of the world's leading centers for biomedical research, to improve disease studies. The project is focused on better understanding cancer, diabetes and heart disease by advancing the study of proteins through the use of an emerging mass spectrometry platform currently under development by AB SCIEX.
› Verified 3 days ago
| NPI Number | 1730317207 |
| Organization Name | GENERATIONS TOO, LLC |
| Address | 4889 Sinclair Rd, Suite 108b, Columbus, OH 43229 |
| Phone Number | 614-440-6231 |
News Archive
InformationConnections.org, the informative website for parents of children with developmental disabilities and chronic diseases, was recently launched by the Marianjoy Medical Library. The National Network of Libraries of Medicine, Greater Midwest Region, provided a grant to create and manage the website.
Repros Therapeutics Inc. today announced it has received IRB approval to commence the low dose Proellex® study. The contract for clinical services was previously awarded to ICON. The new low dose study is designed to explore both safety and signals of efficacy in an escalating dose fashion. The study will test 5 different doses of Proellex (1, 3, 6, 9 and 12 mg) with 1 mg being the first dose tested. In previous studies a 12.5 mg dose was well tolerated and yielded statistically significant efficacy signals for both uterine fibroids and endometriosis.
Some carbonated sodas and energy drinks are loaded with caffeine and can give an unhealthy pick-me-up to unsuspecting consumers, University of Florida researchers warn.
Researchers at Flinders University are expanding work on a promising blood test model to help predict or diagnose head and neck cancer, a difficult cancer to pick up early and treat.
AB SCIEX, a global leader in life science analytical technologies, today announced that it is collaborating with the Samuel Lunenfeld Research Institute of Mount Sinai Hospital, one of the world's leading centers for biomedical research, to improve disease studies. The project is focused on better understanding cancer, diabetes and heart disease by advancing the study of proteins through the use of an emerging mass spectrometry platform currently under development by AB SCIEX.
› Verified 3 days ago
| Quality Rating: | Not Available* |
| * The number of patient episodes for this measure is too small to report. | |
News Archive
InformationConnections.org, the informative website for parents of children with developmental disabilities and chronic diseases, was recently launched by the Marianjoy Medical Library. The National Network of Libraries of Medicine, Greater Midwest Region, provided a grant to create and manage the website.
Repros Therapeutics Inc. today announced it has received IRB approval to commence the low dose Proellex® study. The contract for clinical services was previously awarded to ICON. The new low dose study is designed to explore both safety and signals of efficacy in an escalating dose fashion. The study will test 5 different doses of Proellex (1, 3, 6, 9 and 12 mg) with 1 mg being the first dose tested. In previous studies a 12.5 mg dose was well tolerated and yielded statistically significant efficacy signals for both uterine fibroids and endometriosis.
Some carbonated sodas and energy drinks are loaded with caffeine and can give an unhealthy pick-me-up to unsuspecting consumers, University of Florida researchers warn.
Researchers at Flinders University are expanding work on a promising blood test model to help predict or diagnose head and neck cancer, a difficult cancer to pick up early and treat.
AB SCIEX, a global leader in life science analytical technologies, today announced that it is collaborating with the Samuel Lunenfeld Research Institute of Mount Sinai Hospital, one of the world's leading centers for biomedical research, to improve disease studies. The project is focused on better understanding cancer, diabetes and heart disease by advancing the study of proteins through the use of an emerging mass spectrometry platform currently under development by AB SCIEX.
› Verified 3 days ago
News Archive
InformationConnections.org, the informative website for parents of children with developmental disabilities and chronic diseases, was recently launched by the Marianjoy Medical Library. The National Network of Libraries of Medicine, Greater Midwest Region, provided a grant to create and manage the website.
Repros Therapeutics Inc. today announced it has received IRB approval to commence the low dose Proellex® study. The contract for clinical services was previously awarded to ICON. The new low dose study is designed to explore both safety and signals of efficacy in an escalating dose fashion. The study will test 5 different doses of Proellex (1, 3, 6, 9 and 12 mg) with 1 mg being the first dose tested. In previous studies a 12.5 mg dose was well tolerated and yielded statistically significant efficacy signals for both uterine fibroids and endometriosis.
Some carbonated sodas and energy drinks are loaded with caffeine and can give an unhealthy pick-me-up to unsuspecting consumers, University of Florida researchers warn.
Researchers at Flinders University are expanding work on a promising blood test model to help predict or diagnose head and neck cancer, a difficult cancer to pick up early and treat.
AB SCIEX, a global leader in life science analytical technologies, today announced that it is collaborating with the Samuel Lunenfeld Research Institute of Mount Sinai Hospital, one of the world's leading centers for biomedical research, to improve disease studies. The project is focused on better understanding cancer, diabetes and heart disease by advancing the study of proteins through the use of an emerging mass spectrometry platform currently under development by AB SCIEX.
› Verified 3 days ago
A 1 Nursing Care Inc Location: 2500 Corporate Exchange Drive, Suite 220, Columbus, Ohio 43231 Ratings: NA Phone: (614) 268-3800 | |
Rx Home Healthcare, Inc Location: 1000 East Broad Street, 2nd Floor, Columbus, Ohio 43205 Ratings: NA Phone: (614) 252-7931 | |
Nationwide Children's Hospital Homecare Location: 255 East Main Street, Columbus, Ohio 43215 Ratings: NA Phone: (614) 355-1100 | |
Health Care Plus Location: 1120 Polaris Parkway, Suite 204, Columbus, Ohio 43240 Ratings: Phone: (614) 340-7587 | |
Ohio Living Home Health Greater Columbus Location: 2740 Airport Drive, Suite 140, Columbus, Ohio 43219 Ratings: Phone: (614) 433-0031 | |
Heartland Home Health Care Inc Location: 6500 Busch Boulevard, Suite 210, Columbus, Ohio 43229 Ratings: Phone: (614) 433-0423 |